Last reviewed · How we verify
Pentosan Polysulphate Sodium
At a glance
| Generic name | Pentosan Polysulphate Sodium |
|---|---|
| Also known as | PPS |
| Sponsor | Paradigm Biopharmaceuticals Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain. (PHASE3)
- Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women (PHASE3)
- Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain
- A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
- Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain (PHASE2, PHASE3)
- Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial (PHASE2, PHASE3)
- Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome
- Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pentosan Polysulphate Sodium CI brief — competitive landscape report
- Pentosan Polysulphate Sodium updates RSS · CI watch RSS
- Paradigm Biopharmaceuticals Ltd. portfolio CI